We are reimagining clinical trials
Vial was founded on a mission to reimagine clinical trials and deliver faster and more efficient trials for sponsors
35+
Clinical Research Sites
750+
Trials Completed
6
Therapeutic Areas
Vial's vision
is to empower scientists
to cure all human disease.
Vial is a tech-enabled CRO that delivers faster and 50%+ cheaper trials through an end-to-end technology platform.
Clinical Operations expertise meets product minds from Silicon Valley — together, the team has developed Vial’s technology platform that delivers dramatically faster and more efficient trials for sponsors.
Meet Our Leadership Team
We have raised $100M+ and built a team of ClinOps and technology leaders in order to become a leading global, full-service CRO.
Simon Burns
Co-founder & Chief Executive Officer
LinkedIn
Andrew Brackin
Co-founder & Chief Revenue Officer
LinkedIn
Wendy Pinson
Director of Clinical Operations
LinkedIn
Will MacInnis
VP Finance
LinkedIn
Ananya Shah
VP Operations
LinkedIn
Dan Gallagher
Head of Business Development
LinkedIn
Scientific Advisory Board
Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance research.
Dr. Guru Sonpavde
Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School
Dr. Neeraj Agarwal
Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah
Dr. Arshad Khanani
Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates
Dr. Mark Lebwohl
Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City
Dr. Luke Nordquist
CEO at Urology Cancer Center and XCancer Research
Dr. Arvind Chaudhry
Director of Summit Cancer Centers, Medical Oncologist
Dr. Roberta Brinton
Director of the Center for Innovation in Brain Science at The University of Arizona and founder of NeuTherapeutics.
Dr. David Pariser
Senior physician of Pariser Dermatology Specialist and Principal Investigator
Dr. Arati Rao
Head of Clinical Development at PACT Pharma
Dr. Antoni Ribas
Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA)
Dr. Joseph Merola
Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School
Dr. Jonathan Zung
Chief Development Officer at Evelo Biosciences
Dr. Nathan Pennell
Professor of Medicine and Director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute.
Dr. Paul Karpecki
Director of Corneal Services at Kentucky Eye Institute and Faculty Associate Professor at the University of Pikeville, Kentucky, College of Optometry.
